SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-16-002414
Filing Date
2016-03-30
Accepted
2016-03-30 17:13:24
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-K bostontherapeutics10k.htm 10-K 1558740
2 EXHIBIT 23.1 exh23_1.htm EX-23.1 3833
3 EXHIBIT 23.2 exh23_2.htm EX-23.2 2579
4 EXHIBIT 31.1 exh31_1.htm EX-31.1 16956
5 EXHIBIT 31.2 exh31_2.htm EX-31.2 16730
6 EXHIBIT 32.1 exh32_1.htm EX-32.1 7650
7 EXHIBIT 32.2 exh32_2.htm EX-32.2 7430
  Complete submission text file 0001102624-16-002414.txt   4553162

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bthe-20151231.xml EX-101.INS 647066
9 XBRL TAXONOMY EXTENSION SCHEMA bthe-20151231.xsd EX-101.SCH 43683
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20151231_cal.xml EX-101.CAL 51096
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20151231_def.xml EX-101.DEF 91217
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20151231_lab.xml EX-101.LAB 314275
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20151231_pre.xml EX-101.PRE 223248
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 161540690
SIC: 2834 Pharmaceutical Preparations